AzTrials
AzTrials

StrokeCRESNCT05566782

Cross-sectoral Rehabilitation After Stroke (CRES)

An observational study of Stroke and Neurological Rehabilitation, run by Nordsjaellands Hospital at 1 site in Denmark.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Prospective cohort study during post stroke rehabilitation in hospital and municipality. Participants will be measured with accelerometers, tests in relation to physical function and qualitative interviews. Read more about this study

Who is it for?
Ages 18 years and older
How many people
117 participants
Where
1 siteDenmark
Study dates
23 Jan 2022to Dec 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Participants will be recruited by the PhD-student Gabriel Tafdrup Notkin (GTN) in collaboration with the Department of Neurology. Potential participants will be approached during admission at the Department of Neurology, NOH. Potential participants will be informed about the study orally and in writing. Patients will be informed that participation is voluntary and that they can withdraw from the study at any time. There will be an opportunity for reflection time and for the patient to discuss the decision to participate with relatives or caregivers. If the patient wishes to participate in the study, written consent will be obtained in the form of a completed consent form from the patient and relatives.

Who may be able to join

  • 18 years of age;
  • Hospitalized at Nordsjællands Hospital (NOH) with acute stroke;
  • Discharged from the Department of Neurology NOH with a general rehabilitation plan to one of the eight surrounding municipalities (Hillerød, Allerød, Gribskov, Helsingør, Hørsholm, Halsnæs, Frederikssund Fredensborg);
  • able to give written informed consent;

Who cannot join

  • Poor Danish language skill;
  • Patients refusing any rehabilitation or medically assessed as inevitably dying within 12 weeks;

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Nordsjællands Hospital Department of Neurology

    Hillerød, 3400

Other trials in Denmark

About this study

Prospective cohort study during post stroke rehabilitation in hospital and municipality. Participants will be measured with accelerometers, tests in relation to physical function and qualitative interviews.

Read the detailed description

During and after hospitalization, patients with stroke are subjected to early rehabilitation starting at the hospital stay and continuing after discharge to a municipality. However, the continuity and adherence across sectors is challenged by different locations for the rehabilitation and time gaps from discharge to start in municipality.

This project focuses on the physical activity of patients with stroke measured with 3D accelerometry, the physical performance of the patients measured using the 30 second Chair Stand Test, balance measured with Bergs Balance Scale and health-related quality of life (HRQoL) measured with the 5-level version of European Quality of Life (EQ5D-5L). Furthermore, the patient perspectives and experiences with the rehabilitation plans are explored in semi-structured interviews at the end of the project.

The municipalities in Nordsjælland have been informed regarding the project and all their approvals have been collected prior to expected start in fall 2022. The heads of rehabilitation in the municipalities have approved participation in the research project with regards to follow-up of patients. The municipalities will support the data collection process with a therapist from each municipality working with quality control of the rehabilitation.

Medical subject headings
Stroke, Patient Participation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05566782
Study groupRoleWhat they receive
CRES-participantsThe participants in this cohort will start rehabilitation during their inhospital stay and continue the rehabilitation course during discharge to municipality. The rehabilitation will consist of physical exercise and measurements in relation to accelerometry, physical function and qualitative interviews regarding goal for rehabilitation.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Physical activity measured by step counts and intensity minutes during the day (raw acceleration per time cycle)

    3D Accelerometers able to capture the daily physical activity performed by the participants in terms of intensity minutes and daily step counts (physiological parameter)

    Measured: 10-14 days from hospital discharge til start of rehabilitation in municipality

  2. Change in physical function (30 second chair stand test)

    Tests performed during in hospital stay and at discharge and at start/end of rehabilitation

    Measured: At four timepoints during rehabilitation. Anticipated days for testing: day 1, day 4, day 11, day 95

  3. Change in balance (Bergs Balance Scale)

    Tests performed during in hospital stay and at discharge and at start/end of rehabilitation in municipality. Scores registered in ordinal scale from 0-56 with higher scores indicating lower risk of fall. Bergs Balance Scale consists of 14 test items each with scores ranging from 0, 1, 2, 3 and 4.

    Measured: At four timepoints during rehabilitation. Anticipated days for testing: day 1, day 4, day 11, day 95

  4. Change in Health Related Quality of Life (EQ5D-5L)

    Measurements with EQ5D-5L send electronically to participants with REDcap system

    Measured: Measurement at the start of rehabilitation (day 1) and at the anticipated end of rehabilitation (day 95)

Secondary outcomes (3)
  1. Severity of stroke (Scandinavian Stroke Scale)

    Registration from participants medical records. Scores reported in ordinal scale from 0-58 with higher scores indicating less severe impairment form stroke.

    Overall categories; mild: 43-58 moderate: 26-42 severe: 0-25

    Measured: within 24 hours of admission

  2. Rate of dependence post stroke evaluated by modified Rankin Scale (mRS)

    Evaluation performed by primary investigator with participant. Scores in ordinal scale ranging from 0-6 with higher scores indicating worse outcomes post stroke.

    Measured: Measurement at the discharge from hospital stay (anticipated day 4)

  3. Demographic variables

    age, gender, body mass index, marital status, level of education, employment

    Measured: Measurement at the start of rehabilitation (anticipated day 1 of hospital admission)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Oct 2022
  2. Study start23 Jan 2022
  3. Primary completion5 Oct 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
117 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05566782
Sponsor's protocol ID
CRES&SENS
Acronym
CRES
Status last verified
Nov 2024
First submitted
26 Sep 2022
Last updated
15 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Neurological Rehabilitation, run by Nordsjaellands Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 15 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Physical activity measured by step counts and intensity minutes during the day (raw acceleration per time cycle) (time frame: 10-14 days from hospital discharge til start of rehabilitation in municipality). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in